Status:
TERMINATED
Recurrent Urinary Tract Infections and the Microbiome
Lead Sponsor:
University of Miami
Conditions:
Recurrent Urinary Tract Infection
Eligibility:
FEMALE
18-90 years
Brief Summary
The primary objective is to determine if polymerase chain reaction (PCR) (UTIP™) is more sensitive in identifying urinary tract infections (UTI's) than standard urine cultures.
Eligibility Criteria
Inclusion
- 18 y/o-90 y/o
- Able to consent
- Female
- Group A only: Recurrent UTI (2 UTIs in 6 months)
- Group B only: No history of recurrent UTIs
Exclusion
- Pregnant
- Pelvic radiation
- Urinary retention (\>200 ml residual)
- Greater than Stage 2 prolapse
- Renal calculi
- Immunosuppressed
- Neurologic disorder with significant bladder impairment
- No current UTI via dip stick
Key Trial Info
Start Date :
May 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2023
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04831840
Start Date
May 26 2021
End Date
November 20 2023
Last Update
May 21 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Holy Cross Hospital
Fort Lauderdale, Florida, United States, 33301
2
University of Miami
Miami, Florida, United States, 33136